[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.111.118. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
June 1987

Cutaneous Thick MelanomaPrognosis and Treatment

Author Affiliations

From the Division of Surgical Oncology, Departments of Surgery (Drs Schneebaum, Briele, Walker, Greager, Wood, and Das Gupta) and Pathology (Dr Ronan), and the Section of Biometry, Research Resources Center (Mr Patel), University of Illinois at Chicago and Cook County Hospital; the Hektoen Institute for Medical Research (Drs Schneebaum, Briele, Walker, Greager, Wood, and Das Gupta); and the West Side Veterans Administration Hospital (Drs Schneebaum, Briele, Walker, Greager, Wood, and Das Gupta), Chicago.

Arch Surg. 1987;122(6):707-711. doi:10.1001/archsurg.1987.01400180089017
Abstract

• Among proponents of elective lymph node dissection (ELND) for clinical stage I melanoma, controversy exists as to whether there is an upper limit of tumor thickness beyond which ELND should not be considered. We reviewed 169 patients with clinical stage I and II melanoma that was greater than or equal to 3.0 mm thick and who were treated at the University of Illinois Hospital, Chicago. Of 139 patients with clinical stage I disease, 117 underwent ELND. Five- and ten-year survival rates were 55.7% and 48.9%, respectively. Multifactorial analysis demonstrated that anatomical location, level, pathologic stage, and ulceration were the best predictors of survival. Thickness did not emerge as a significant variable. Our findings do not support basing treatment decisions, eg, ELND in this group of patients, solely on the thickness of the primary tumor. We continue to recommend ELND in patients with either intermediate or thick melanomas.

(Arch Surg 1987;122:707-711)

References
1.
Balch CM, Cascinelli N, Milton GW:  Elective lymph node dissection: Pros and cons , in Balch CM, Milton GW, Shaw HM, Soong SJ (eds): Cutaneous Melanoma: Clinical Management and Treatment: Results Worldwide . Philadelphia, JB Lippincott, 1985, pp 131-157.
2.
Veronisi U, Adamus J, Bandiera DC, et al:  Inefficacy of immediate node dissection in stage I melanoma of the limbs . N Engl J Med 1977;297: 627-630.Article
3.
Veronisi U, Adamus J, Bandiera DC, et al:  Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities . Cancer 1982;49:2420-2430.Article
4.
Sim FH, Taylor WF, Ivins JC, et al:  A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: Preliminary results . Cancer 1978;41:948-956.Article
5.
Sim FH, Taylor WF, Pritchard DI, et al:  Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study . Mayo Clin Proc 1986;61:697-705.Article
6.
Balch CM, Soong SJ, Murad TM, et al:  A multifactorial analysis of melanoma: II. Prognostic factors in patients with stage I (localized) melanoma . Surgery 1979;86:343-351.
7.
Das Gupta TK:  Results of treatment of 269 patients with primary cutaneous melanoma: A five-year prospective study . Ann Surg 1977;186: 201-209.Article
8.
Milton GW, Shaw HM, McCarthy WH, et al:  Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patients . Br J Surg 1982;69:108-111.Article
9.
Reintgen DS, Cox EB, McCarthy KS Jr, et al:  Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma . Ann Surg 1983;198:379-384.Article
10.
Wanebo HJ, Woodruff J, Fortner JG:  Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage) . Cancer 1975;35:666-676.Article
11.
Balch CM, Soong SJ, Milton GW, et al:  A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia . Ann Surg 1982;196:677-684.Article
12.
McCarthy WH, Shaw HM, Milton GW:  Efficacy of elective lymph node dissection in 2347 patients with clinical stage I malignant melanoma . Surg Gynecol Obstet 1985;161:575-580.
13.
Day CL Jr, Lew RA, Mihm MC, et al:  A multivariate analysis of prognostic factors for melanoma patients with lesions ≥3.65 mm in thickness . Ann Surg 1982;195:44-49.Article
14.
Kaplan EL, Meier P:  Non-parametric estimation from incomplete observations . J Am Statist Assoc 1958;53:457-481.Article
15.
Breslow N:  A generalized Kruskal-Wallis test for comparing κ samples subject to unequal patterns of censorship . Biometrika 1970;57:579-594.Article
16.
Cox DR:  Regression model and life tables . J R Statist Soc Br 1972;34:187-220.
17.
Balch CM, Soong SJ, Shaw HM:  An analysis of prognostic factors in 4000 patients with cutaneous melanoma , in Balch CM, Milton GW, Shaw HM, et al (eds): Cutaneous Melanoma: Clinical Management and Treatment: Results Worldwide . Philadelphia, JB Lippincott, 1985, pp 321-352.
×